Application of lncrna11496 in the diagnosis and treatment of toxoplasmosis

A technology for toxoplasmosis and toxoplasmosis, applied in the fields of biomedicine and molecular biology, can solve the problems of decreased antibody level, low specificity and sensitivity, and no specific target for brain toxoplasmosis diagnosis and treatment
CN109929939BActive Publication Date: 2021-02-05SHANDONG UNIV
2 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN Β· China
Patent Type
Patents(China)
Current Assignee / Owner
SHANDONG UNIV
Publication Date
2021-02-05

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention provides the application of lncRNA11496 in the diagnosis and treatment of toxoplasmosis, which belongs to the technical field of biomedicine and molecular biology. The study found that NONMMUG011496 (lncRNA11496) was significantly down-regulated in the brain tissue of Toxoplasma gondii-infected mice infected by microarray; at the same time, the expression of lncRNA11496 in the brain tissue of Toxoplasma gondii chronically infected mice affected the proliferation, differentiation and apoptosis of nerve cells, and Toxoplasma infection is closely related. lncRNA11496 is a non-coding RNA discovered for the first time in brain tissue chronically infected by Toxoplasma gondii. Therefore, lncRNA11496 can be used as an important biological target, which provides a basis for the diagnosis of toxoplasmosis encephalopathy and the development of anti-toxoplasma drugs based on lncRNA11496, which has good practical application value.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of biomedicine and molecular biology, and specifically relates to the application of lncRNA11496 in the diagnosis and treatment of toxoplasmosis. Background technique

[0002] The information disclosed in this background section is only intended to increase the understanding of the general background of the present invention, and is not necessarily taken as an acknowledgment or any form of suggestion that the information constitutes the prior art already known to those skilled in the art.

[0003] Toxoplasma gondii is an obligate intracellular parasite. The first human case was reported in 1908. It was discovered at the same time as animal toxoplasmosis. About 500 to 1 billion people in the world are infected with toxoplasmosis. Humans have been fighting against this disease for more than a century, but the disease is still around the world. raging. In my country, about 80,000 to 90,000 newborns are born e...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More